Global CNS Biomarker Market to Exceed USD 17.89 Billion by 2031, Fueled by Demand for Early Diagnosis and Precision Neurology
[Boston, 4th July 2025] – Clearview Market Insights (CVMI) reports that the global CNS biomarker market will grow from USD 7.93 billion in 2024 to USD 17.89 billion by 2031, with a CAGR of 12.3%. The market is driven by the increasing prevalence of neurological disorders, rising demand for early diagnostics, and advances in precision medicine in neuroscience. “CNS biomarkers are...
0 التعليقات 0 المشاركات 184 مشاهدة 0 معاينة
إعلان مُمول